Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 217 to 226 of 226 entries
Sorted by: Best Match Show Resources per page
Herpesvirus DNA polymerase: Structures, functions, and mechanisms.

The Enzymes

Coen DM, Lawler JL, Abraham J.
PMID: 34861935
Enzymes. 2021;50:133-178. doi: 10.1016/bs.enz.2021.09.003. Epub 2021 Nov 02.

Herpesviruses comprise a family of DNA viruses that cause a variety of human and veterinary diseases. During productive infection, mammalian, avian, and reptilian herpesviruses replicate their genomes using a set of conserved viral proteins that include a two subunit...

Cite
Coen DM, Lawler JL, Abraham J. Herpesvirus DNA polymerase: Structures, functions, and mechanisms. Enzymes. 2021;50:133-178doi: 10.1016/bs.enz.2021.09.003.
Coen, D. M., Lawler, J. L., & Abraham, J. (2021). Herpesvirus DNA polymerase: Structures, functions, and mechanisms. The Enzymes, 50133-178. https://doi.org/10.1016/bs.enz.2021.09.003
Coen, Donald M, et al. "Herpesvirus DNA polymerase: Structures, functions, and mechanisms." The Enzymes vol. 50 (2021): 133-178. doi: https://doi.org/10.1016/bs.enz.2021.09.003
Coen DM, Lawler JL, Abraham J. Herpesvirus DNA polymerase: Structures, functions, and mechanisms. Enzymes. 2021;50:133-178. doi: 10.1016/bs.enz.2021.09.003. Epub 2021 Nov 02. PMID: 34861935.
Copy Download .nbib Format: NLM
Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system.

ACS chemical neuroscience

Lebois EP, Bridges TM, Lewis LM, Dawson ES, Kane AS, Xiang Z, Jadhav SB, Yin H, Kennedy JP, Meiler J, Niswender CM, Jones CK, Conn PJ, Weaver CD, Lindsley CW.
PMID: 21961051
ACS Chem Neurosci. 2010;1(2):104-121. doi: 10.1021/cn900003h.

Cholinergic transmission in the forebrain is mediated primarily by five subtypes of muscarinic acetylcholine receptors (mAChRs), termed M(1)-M(5). Of the mAChR subtypes, M(1) is among the most heavily expressed in regions that are critical for learning and memory, and...

Cite
Lebois EP, Bridges TM, Lewis LM, et al. Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system. ACS Chem Neurosci. 2010;1(2):104-121doi: 10.1021/cn900003h.
Lebois, E. P., Bridges, T. M., Lewis, L. M., Dawson, E. S., Kane, A. S., Xiang, Z., Jadhav, S. B., Yin, H., Kennedy, J. P., Meiler, J., Niswender, C. M., Jones, C. K., Conn, P. J., Weaver, C. D., & Lindsley, C. W. (2010). Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system. ACS chemical neuroscience, 1(2), 104-121. https://doi.org/10.1021/cn900003h
Lebois, Evan P, et al. "Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system." ACS chemical neuroscience vol. 1,2 (2010): 104-121. doi: https://doi.org/10.1021/cn900003h
Lebois EP, Bridges TM, Lewis LM, Dawson ES, Kane AS, Xiang Z, Jadhav SB, Yin H, Kennedy JP, Meiler J, Niswender CM, Jones CK, Conn PJ, Weaver CD, Lindsley CW. Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system. ACS Chem Neurosci. 2010;1(2):104-121. doi: 10.1021/cn900003h. PMID: 21961051; PMCID: PMC3180826.
Copy Download .nbib Format: NLM
Pregnant Smokers' Intention to Switch From Cigarettes to E-Cigarettes: A Reasoned Action Approach.

Women's health issues : official publication of the Jacobs Institute of Women's Health

Dobbs PD, Branscum P, Cohn AM, Tackett AP, Comiford AL.
PMID: 34452825
Womens Health Issues. 2021 Nov-Dec;31(6):540-549. doi: 10.1016/j.whi.2021.07.005. Epub 2021 Aug 25.

INTRODUCTION: This study used the reasoned action approach (RAA) to examine 1) factors associated with pregnant smokers' intention to switch from cigarettes to e-cigarettes and 2) the influence that intention to switch had on future expectations to resume cigarette...

Cite
Dobbs PD, Branscum P, Cohn AM, et al. Pregnant Smokers' Intention to Switch From Cigarettes to E-Cigarettes: A Reasoned Action Approach. Womens Health Issues. 2021;31(6):540-549doi: 10.1016/j.whi.2021.07.005.
Dobbs, P. D., Branscum, P., Cohn, A. M., Tackett, A. P., & Comiford, A. L. (2021). Pregnant Smokers' Intention to Switch From Cigarettes to E-Cigarettes: A Reasoned Action Approach. Women's health issues : official publication of the Jacobs Institute of Women's Health, 31(6), 540-549. https://doi.org/10.1016/j.whi.2021.07.005
Dobbs, Page D, et al. "Pregnant Smokers' Intention to Switch From Cigarettes to E-Cigarettes: A Reasoned Action Approach." Women's health issues : official publication of the Jacobs Institute of Women's Health vol. 31,6 (2021): 540-549. doi: https://doi.org/10.1016/j.whi.2021.07.005
Dobbs PD, Branscum P, Cohn AM, Tackett AP, Comiford AL. Pregnant Smokers' Intention to Switch From Cigarettes to E-Cigarettes: A Reasoned Action Approach. Womens Health Issues. 2021 Nov-Dec;31(6):540-549. doi: 10.1016/j.whi.2021.07.005. Epub 2021 Aug 25. PMID: 34452825.
Copy Download .nbib Format: NLM
Corrigendum to "Correlates of e-cigarette use among adults initiating smoking cessation treatment" [Drug Alcohol Depend. 224 (2021) 108724].

Drug and alcohol dependence

Boozary LK, Frank-Pearce SG, Alexander AC, Waring JJC, Ehlke SJ, Businelle MS, Cohn AM, Kendzor DE.
PMID: 34583106
Drug Alcohol Depend. 2021 Nov 01;228:109035. doi: 10.1016/j.drugalcdep.2021.109035. Epub 2021 Sep 25.

No abstract available.

Cite
Boozary LK, Frank-Pearce SG, Alexander AC, et al. Corrigendum to "Correlates of e-cigarette use among adults initiating smoking cessation treatment" [Drug Alcohol Depend. 224 (2021) 108724]. Drug Alcohol Depend. 2021;228:109035doi: 10.1016/j.drugalcdep.2021.109035.
Boozary, L. K., Frank-Pearce, S. G., Alexander, A. C., Waring, J. J. C., Ehlke, S. J., Businelle, M. S., Cohn, A. M., & Kendzor, D. E. (2021). Corrigendum to "Correlates of e-cigarette use among adults initiating smoking cessation treatment" [Drug Alcohol Depend. 224 (2021) 108724]. Drug and alcohol dependence, 228109035. https://doi.org/10.1016/j.drugalcdep.2021.109035
Boozary, Laili Kharazi, et al. "Corrigendum to "Correlates of e-cigarette use among adults initiating smoking cessation treatment" [Drug Alcohol Depend. 224 (2021) 108724]." Drug and alcohol dependence vol. 228 (2021): 109035. doi: https://doi.org/10.1016/j.drugalcdep.2021.109035
Boozary LK, Frank-Pearce SG, Alexander AC, Waring JJC, Ehlke SJ, Businelle MS, Cohn AM, Kendzor DE. Corrigendum to "Correlates of e-cigarette use among adults initiating smoking cessation treatment" [Drug Alcohol Depend. 224 (2021) 108724]. Drug Alcohol Depend. 2021 Nov 01;228:109035. doi: 10.1016/j.drugalcdep.2021.109035. Epub 2021 Sep 25. PMID: 34583106.
Copy Download .nbib Format: NLM
Internalizing problems are associated with initiation and past 30-Day use of flavored tobacco products.

Addictive behaviors

Ganz O, Cohn AM, Goodwin RD, Giovenco DP, Wackowski OA, Talbot EM, Delnevo CD.
PMID: 34763300
Addict Behav. 2022 Feb;125:107162. doi: 10.1016/j.addbeh.2021.107162. Epub 2021 Oct 26.

OBJECTIVE: Tobacco use remains disproportionately common among adults with internalizing problems. The rising prevalence of flavored tobacco use among this population may be a contributing factor. Using data from Wave 4 of the Population Assessment of Tobacco and Health...

Cite
Ganz O, Cohn AM, Goodwin RD, et al. Internalizing problems are associated with initiation and past 30-Day use of flavored tobacco products. Addict Behav. 2021;125:107162doi: 10.1016/j.addbeh.2021.107162.
Ganz, O., Cohn, A. M., Goodwin, R. D., Giovenco, D. P., Wackowski, O. A., Talbot, E. M., & Delnevo, C. D. (2022). Internalizing problems are associated with initiation and past 30-Day use of flavored tobacco products. Addictive behaviors, 125107162. https://doi.org/10.1016/j.addbeh.2021.107162
Ganz, Ollie, et al. "Internalizing problems are associated with initiation and past 30-Day use of flavored tobacco products." Addictive behaviors vol. 125 (2022): 107162. doi: https://doi.org/10.1016/j.addbeh.2021.107162
Ganz O, Cohn AM, Goodwin RD, Giovenco DP, Wackowski OA, Talbot EM, Delnevo CD. Internalizing problems are associated with initiation and past 30-Day use of flavored tobacco products. Addict Behav. 2022 Feb;125:107162. doi: 10.1016/j.addbeh.2021.107162. Epub 2021 Oct 26. PMID: 34763300; PMCID: PMC8637941.
Copy Download .nbib Format: NLM
Simulation-Based Training Improves Fellows' Competence in Brain Death Discussion and Declaration.

The neurologist

Chen PM, Trando A, LaBuzetta JN.
PMID: 34842565
Neurologist. 2021 Nov 26;27(1):6-10. doi: 10.1097/NRL.0000000000000354.

BACKGROUND: Despite well-defined American Academy of Neurology guidelines for death by whole brain criteria (brain death), there is marked variability in national practice, which some have attributed to lack of formal education. Further, communication with surrogates and families about...

Cite
Chen PM, Trando A, LaBuzetta JN. Simulation-Based Training Improves Fellows' Competence in Brain Death Discussion and Declaration. Neurologist. 2021;27(1):6-10doi: 10.1097/NRL.0000000000000354.
Chen, P. M., Trando, A., & LaBuzetta, J. N. (2021). Simulation-Based Training Improves Fellows' Competence in Brain Death Discussion and Declaration. The neurologist, 27(1), 6-10. https://doi.org/10.1097/NRL.0000000000000354
Chen, Patrick M, et al. "Simulation-Based Training Improves Fellows' Competence in Brain Death Discussion and Declaration." The neurologist vol. 27,1 (2021): 6-10. doi: https://doi.org/10.1097/NRL.0000000000000354
Chen PM, Trando A, LaBuzetta JN. Simulation-Based Training Improves Fellows' Competence in Brain Death Discussion and Declaration. Neurologist. 2021 Nov 26;27(1):6-10. doi: 10.1097/NRL.0000000000000354. PMID: 34842565.
Copy Download .nbib Format: NLM
Finding MyVOICE: A Mixed-Methods Examination of Health Outcomes of Young Adults with Chronic Illness Transitioning from Pediatric to Adult Health Care.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners

Wright S, Conn BM, Shahinian M, Keyllian C, Tanaka D, Iverson E.
PMID: 34325977
J Pediatr Health Care. 2021 Nov-Dec;35(6):610-620. doi: 10.1016/j.pedhc.2021.06.002. Epub 2021 Jul 27.

INTRODUCTION: This study examines health use outcomes of young adults with chronic illness following participation in a transition program and identifies variables that impact outcomes.METHOD: A sample of 119 ethnically diverse, low-income young adults (mean age = 21.8 years)...

Cite
Wright S, Conn BM, Shahinian M, et al. Finding MyVOICE: A Mixed-Methods Examination of Health Outcomes of Young Adults with Chronic Illness Transitioning from Pediatric to Adult Health Care. J Pediatr Health Care. 2021;35(6):610-620doi: 10.1016/j.pedhc.2021.06.002.
Wright, S., Conn, B. M., Shahinian, M., Keyllian, C., Tanaka, D., & Iverson, E. (2021). Finding MyVOICE: A Mixed-Methods Examination of Health Outcomes of Young Adults with Chronic Illness Transitioning from Pediatric to Adult Health Care. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners, 35(6), 610-620. https://doi.org/10.1016/j.pedhc.2021.06.002
Wright, Stephanie, et al. "Finding MyVOICE: A Mixed-Methods Examination of Health Outcomes of Young Adults with Chronic Illness Transitioning from Pediatric to Adult Health Care." Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners vol. 35,6 (2021): 610-620. doi: https://doi.org/10.1016/j.pedhc.2021.06.002
Wright S, Conn BM, Shahinian M, Keyllian C, Tanaka D, Iverson E. Finding MyVOICE: A Mixed-Methods Examination of Health Outcomes of Young Adults with Chronic Illness Transitioning from Pediatric to Adult Health Care. J Pediatr Health Care. 2021 Nov-Dec;35(6):610-620. doi: 10.1016/j.pedhc.2021.06.002. Epub 2021 Jul 27. PMID: 34325977.
Copy Download .nbib Format: NLM
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses.

Cell

Cui C, Wang J, Fagerberg E, Chen PM, Connolly KA, Damo M, Cheung JF, Mao T, Askari AS, Chen S, Fitzgerald B, Foster GG, Eisenbarth SC, Zhao H, Craft J, Joshi NS.
PMID: 34852236
Cell. 2021 Dec 09;184(25):6101-6118.e13. doi: 10.1016/j.cell.2021.11.007. Epub 2021 Nov 30.

CD4 T follicular helper (TFH) cells support B cells, which are critical for germinal center (GC) formation, but the importance of TFH-B cell interactions in cancer is unclear. We found enrichment of TFH cell transcriptional signature correlates with GC...

Cite
Cui C, Wang J, Fagerberg E, et al. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell. 2021;184(25):6101-6118.e13doi: 10.1016/j.cell.2021.11.007.
Cui, C., Wang, J., Fagerberg, E., Chen, P. M., Connolly, K. A., Damo, M., Cheung, J. F., Mao, T., Askari, A. S., Chen, S., Fitzgerald, B., Foster, G. G., Eisenbarth, S. C., Zhao, H., Craft, J., & Joshi, N. S. (2021). Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell, 184(25), 6101-6118.e13. https://doi.org/10.1016/j.cell.2021.11.007
Cui, Can, et al. "Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses." Cell vol. 184,25 (2021): 6101-6118.e13. doi: https://doi.org/10.1016/j.cell.2021.11.007
Cui C, Wang J, Fagerberg E, Chen PM, Connolly KA, Damo M, Cheung JF, Mao T, Askari AS, Chen S, Fitzgerald B, Foster GG, Eisenbarth SC, Zhao H, Craft J, Joshi NS. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell. 2021 Dec 09;184(25):6101-6118.e13. doi: 10.1016/j.cell.2021.11.007. Epub 2021 Nov 30. PMID: 34852236.
Copy Download .nbib Format: NLM
Predictors of nonsentinel nodal involvement to aid intraoperative decision making in breast cancer patients with positive sentinel lymph nodes.

ISRN oncology

Tan EY, Ho B, Chen JJ, Ho PW, Teo C, Earnest A, Chan PM.
PMID: 22091423
ISRN Oncol. 2011;2011:539503. doi: 10.5402/2011/539503. Epub 2011 Aug 16.

Background. Up to 60% of patients with a positive sentinel lymph node (SLN) have no additional nodal involvement and do not benefit from completion axillary lymph node dissection (ALND). We aim to identify factors predicting for non-SLN involvement and...

Cite
Tan EY, Ho B, Chen JJ, et al. Predictors of nonsentinel nodal involvement to aid intraoperative decision making in breast cancer patients with positive sentinel lymph nodes. ISRN Oncol. 2011;2011:539503doi: 10.5402/2011/539503.
Tan, E. Y., Ho, B., Chen, J. J., Ho, P. W., Teo, C., Earnest, A., & Chan, P. M. (2011). Predictors of nonsentinel nodal involvement to aid intraoperative decision making in breast cancer patients with positive sentinel lymph nodes. ISRN oncology, 2011539503. https://doi.org/10.5402/2011/539503
Tan, Ern Yu, et al. "Predictors of nonsentinel nodal involvement to aid intraoperative decision making in breast cancer patients with positive sentinel lymph nodes." ISRN oncology vol. 2011 (2011): 539503. doi: https://doi.org/10.5402/2011/539503
Tan EY, Ho B, Chen JJ, Ho PW, Teo C, Earnest A, Chan PM. Predictors of nonsentinel nodal involvement to aid intraoperative decision making in breast cancer patients with positive sentinel lymph nodes. ISRN Oncol. 2011;2011:539503. doi: 10.5402/2011/539503. Epub 2011 Aug 16. PMID: 22091423; PMCID: PMC3199941.
Copy Download .nbib Format: NLM
Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease.

Journal of vascular and interventional radiology : JVIR

Arendt VA, Mabud TS, Kuo WT, Jeon GS, An X, Cohn DM, Fu JX, Hofmann LV.
PMID: 34478851
J Vasc Interv Radiol. 2021 Nov;32(11):1584-1590. doi: 10.1016/j.jvir.2021.08.016. Epub 2021 Aug 31.

PURPOSE: To determine whether subtherapeutic anticoagulation regimens are noninferior to therapeutic anticoagulation regimens following stent placement for nonthrombotic lower extremity venous disease.MATERIALS AND METHODS: Fifty-one consecutive patients (88% women; mean age, 44 years) who underwent stent placement for nonthrombotic...

Cite
Arendt VA, Mabud TS, Kuo WT, et al. Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease. J Vasc Interv Radiol. 2021;32(11):1584-1590doi: 10.1016/j.jvir.2021.08.016.
Arendt, V. A., Mabud, T. S., Kuo, W. T., Jeon, G. S., An, X., Cohn, D. M., Fu, J. X., & Hofmann, L. V. (2021). Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease. Journal of vascular and interventional radiology : JVIR, 32(11), 1584-1590. https://doi.org/10.1016/j.jvir.2021.08.016
Arendt, Victoria A, et al. "Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease." Journal of vascular and interventional radiology : JVIR vol. 32,11 (2021): 1584-1590. doi: https://doi.org/10.1016/j.jvir.2021.08.016
Arendt VA, Mabud TS, Kuo WT, Jeon GS, An X, Cohn DM, Fu JX, Hofmann LV. Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease. J Vasc Interv Radiol. 2021 Nov;32(11):1584-1590. doi: 10.1016/j.jvir.2021.08.016. Epub 2021 Aug 31. PMID: 34478851.
Copy Download .nbib Format: NLM
Showing 217 to 226 of 226 entries